Formal Complaint Recipients
President Donald J. Trump
The White House
Dr. Marty Makary, M.D., M.P.H.
FDA Commissioner
Dr. Vinay Prasad, M.D.
Director, CBER
Robert F. Kennedy Jr.
Secretary, HHS
Office of Inspector General
Department of HHS
Mr. President, Here Is Your Answer
On January 6, 2022, U.S. District Judge Mark T. Pittman ordered the FDA to disclose records that Pfizer originally requested be kept secret for 75 years. Independent analysis of those records — drawn from the sponsors' own documents — reveals systematic fraud across five categories that made the product appear safer and more effective than observed in clinical trials.
1
Manufacturing Process Substitution: The vaccine tested (Process 1) differed from the product distributed (Process 2). Less than 1.2% received the commercial version before EUA. Process 2 showed HIGHER adverse events.
2
DNA Contamination: All 32 vials tested exceeded limits by 36-627×. SV40 oncogenic sequences were intentionally hidden from regulators by editing auto-generated plasmid maps.
3
Gene Therapy Misclassification: Products meet FDA's gene therapy definition but were routed to wrong advisory committee to bypass 15-year safety monitoring requirements.
4
Trial Blinding Failures: Statistical evidence shows trial staff knew who received vaccine vs. placebo and treated them differently (p<0.00001), compromising trial validity.
5
Concealed Deaths & Data: At least 2 cardiac deaths were known before EUA deadline but not reported. 301 subject records are missing from datasets.
⚠️ CRITICAL: These are not minor technical violations or differences in scientific interpretation. They represent systematic compromises of regulatory integrity across multiple dimensions: clinical trial conduct, manufacturing consistency, safety reporting, product classification, and data transparency.
"Pfizer's 90-day post-marketing data documented 1,223 deaths occurring shortly after vaccination. Given the temporal proximity to vaccine administration — with a substantial percentage of deaths occurring within 48 hours — these deaths suggest potential causation rather than mere correlation. This safety signal should have immediately halted product distribution. For context, the 1976 Swine Flu vaccination program was suspended after 25-32 reported deaths."
— Dr. Peter McCullough, Cardiologist
Why the Application Integrity Policy Exists
The AIP was established in 1991 following the Generic Drug Scandal. The current allegations bear disturbing parallels:
1980s Generic Drug Scandal
•
Companies submitted false bioequivalence data
•
Bribing of FDA officials
•
Switching samples during testing
•
Keeping separate sets of records
Current Pfizer Allegations
•
Process 1 data presented for Process 2 approval
•
Concealed mortality and adverse events
•
Manipulated datasets between submissions
•
Systematic regulatory bypass
ℹ️ The Generic Drug Scandal resulted in 22 companies receiving criminal convictions, 70 individual criminal convictions, over $50 million in fines, and creation of the Application Integrity Policy. The current allegations involve conduct of equal or greater severity affecting a far larger population.
1
Invoke AIP on all Pfizer/BioNTech COVID-19 vaccine applications (EUA, BLA, supplements)
2
Defer Scientific Review pending completion of validity assessment
3
Issue Preservation Notices for all relevant documents and electronic records
4
Coordinate with OCI regarding potential criminal referrals to Department of Justice
"Trust cannot be restored through mandates or incentives alone – only through a comprehensive, transparent examination of every mistake made during and after Operation Warp Speed. The FDA's AIP audit marks only the initial step in what must be a thorough and ongoing investigation."
— DNA Integrity Project